SIRT6: A potential therapeutic target for diabetic cardiomyopathy.

Wu, Tao; Qu, Yiwei; Xu, Shengjie; Wang, Yong; Liu, Xue; Ma, Dufang

Wu, Tao; Qu, Yiwei; Xu, Shengjie; Wang, Yong; Liu, Xue; Ma, Dufang.

Affiliation

Wu T; College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Qu Y; College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Xu S; College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Wang Y; Department of Cardiology, Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan, China.
Liu X; College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Ma D; Department of Cardiology, Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan, China.

FASEB J ; 37(8): e23099, 2023 08.

Article in En | MEDLINE | ID: mdl-37462453

Subject(s)

Diabetes Mellitus; Diabetic Cardiomyopathies; Sirtuins; Humans; Diabetic Cardiomyopathies/metabolism; Myocardium/metabolism; Myocytes, Cardiac/metabolism; Mitochondria/metabolism; Sirtuins/metabolism; Diabetes Mellitus/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sirtuins / Diabetes Mellitus / Diabetic Cardiomyopathies Limits: Humans Language: En Journal: FASEB J Journal subject: BIOLOGIA / FISIOLOGIA Year: 2023 Document type: Article Affiliation country: China Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google